Title : [Treatment strategies for ANCA-associated vasculitides].

Pub. Date : 2015 Jun

PMID : 26031284






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: In active severe AAV a combination of prednisolone and cyclophosphamide or rituximab leads to a therapeutic response in approximately 90 % of cases. Cyclophosphamide adeno-associated virus integration site 1 Homo sapiens